glucocorticoid: be prescribed during radiation

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents hormone
Weight: 0.78
, drug
Weight: 0.62
, immune response
Weight: 0.59
, medication
Weight: 0.52
, factor
Weight: 0.52
Siblings vasopressin
Weight: 0.41
, prolactin
Weight: 0.39
, progesterone
Weight: 0.39
, estrogen
Weight: 0.39
, serotonin
Weight: 0.39

Related properties

Property Similarity
be prescribed during radiation 1.00
be prescribed during chemotherapy 0.85
be administered after adrenalectomy 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.24
Rule weight: 0.28
Evidence weight: 0.85
Similarity weight: 1.00
Evidence: 0.83
Plausible(glucocorticoid, be prescribed during radiation)
Evidence: 0.87
¬ Salient(glucocorticoid, be prescribed during radiation)

Similarity expansion

0.64
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.85
Evidence: 0.88
Typical(glucocorticoid, be prescribed during radiation)
Evidence: 0.93
¬ Typical(glucocorticoid, be prescribed during chemotherapy)
0.64
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.85
Evidence: 0.87
Salient(glucocorticoid, be prescribed during radiation)
Evidence: 0.91
¬ Salient(glucocorticoid, be prescribed during chemotherapy)
0.62
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.85
Evidence: 0.83
Plausible(glucocorticoid, be prescribed during radiation)
Evidence: 0.88
¬ Plausible(glucocorticoid, be prescribed during chemotherapy)
0.60
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.76
Evidence: 0.87
Salient(glucocorticoid, be prescribed during radiation)
Evidence: 0.49
¬ Salient(glucocorticoid, be administered after adrenalectomy)
0.59
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.76
Evidence: 0.88
Typical(glucocorticoid, be prescribed during radiation)
Evidence: 0.71
¬ Typical(glucocorticoid, be administered after adrenalectomy)
0.58
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.76
Evidence: 0.83
Plausible(glucocorticoid, be prescribed during radiation)
Evidence: 0.56
¬ Plausible(glucocorticoid, be administered after adrenalectomy)
0.55
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.85
Evidence: 0.55
Remarkable(glucocorticoid, be prescribed during radiation)
Evidence: 0.53
¬ Remarkable(glucocorticoid, be prescribed during chemotherapy)
0.54
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.76
Evidence: 0.55
Remarkable(glucocorticoid, be prescribed during radiation)
Evidence: 0.35
¬ Remarkable(glucocorticoid, be administered after adrenalectomy)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.94
Similarity weight: 1.00
Evidence: 0.87
Salient(glucocorticoid, be prescribed during radiation)
Evidence: 0.88
¬ Typical(glucocorticoid, be prescribed during radiation)
Evidence: 0.55
¬ Remarkable(glucocorticoid, be prescribed during radiation)

Typical implies Plausible

0.41
Rule weight: 0.48
Evidence weight: 0.85
Similarity weight: 1.00
Evidence: 0.83
Plausible(glucocorticoid, be prescribed during radiation)
Evidence: 0.88
¬ Typical(glucocorticoid, be prescribed during radiation)